Patent directory · USPTO A61K / A61P
Patents matching “Regents of the University of CA”
3,501 pharma patents match "Regents of the University of CA" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,501 pharmaceutical patents matching "Regents of the University of CA" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7256171
Use of core 2 G1cNAc transferase inhibitors in treating inflammation
granted -
US 7255850
Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis
granted -
US 7252819
Methods and compositions for correction of cardiac conduction disturbances
granted -
US 7253275
Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
granted -
US 7244826
Internalizing ERB2 antibodies
granted -
US 7244423
Methods for therapy of neurodegenerative disease of the brain
granted -
US 7241571
Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
granted -
US 7238489
Identification of sortase gene
granted -
US 7238525
Strategy for leukemia therapy
granted -
US 7238369
Cationic liposome delivery of taxanes to angiogenic blood vessels
granted -
US 7238708
Glucose sensor
granted -
US 7238475
Apolipoprotein gene involved in lipid metabolism
granted -
US 7235573
Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
granted -
US 7235236
Polynucleotide encoding human adenylylcyclase VI and uses thereof for enhancing cardiac function
granted -
US 7235577
Non-peptide inhibition of T-lymphocyte activation and therapies related thereto
granted -
US 7232570
ERAAP modulators regulate immune responses
granted -
US 7229628
Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
granted -
US 7229770
YKL-40 as a marker and prognostic indicator for cancers
granted -
US 7230086
Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices
granted -
US 7226588
Non-toxic mutants of pathogenic gram-negative bacteria
granted -
US 7226609
Sodium dodecyl sulfate compositions for inactivating prions
granted -
US 7223726
Apolipoprotein A-I mutant proteins having cysteine substitutions and polynucleotides encoding same
granted -
US 7223406
Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
granted -
US 7220421
Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of Moraxella bovis infections
granted